
Novo Nordisk partners with GoodRx for $499 monthly Ozempic, Wegovy (GDRX:NASDAQ) - Seeking Alpha
Sanofi to offer insulin product for $35 to all Americans through GoodRx
GDRX, AAOI and TSP are among after hour movers
1.19BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US38246G1085
CUSIP
38246G108
Sector
Healthcare
Industry
Health Information Services
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
71.00
PEG Ratio
-
Book Value
1.90
Dividend Share
-
Dividend Yield
-
Earnings Share
0.05
Wall Street Target Price
3.95
EPS Estimate Current Year
0.30
EPS Estimate Next Year
0.35
EPS Estimate Current Quarter
0.0797
EPS Estimate Next Quarter
0.0797
Most Recent Quarter
-
Revenue TTM
785,230,016
Gross Profit TTM
713,192,000
EBITDA
108,776,000
Profit Margin
2.07%
Return On Assets TTM
3.05%
Return On Equity TTM
2.52%
Revenue Per Share TTM
2.294
Qtly Revenue Growth YOY
-1.30%
Diluted Eps TTM
0.05
Qtly Earnings Growth YOY
-44.50%
Trailing PE
71.00
Forward PE
10
Price Sales TTM
1.5423
Price Book MRQ
1.8411
Enterprise Value Revenue
1
Enterprise Value EBITDA
8
69.10
4.32%116.80
2.95%132.14
0.00%76.82
-3.77%301.00
-2.16%53.75
-1.96%27.66
-1.89%102.03
-1.61%32.50
-1.13%5.70
-0.35%